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Abstract
Background: Physicians' acceptance of clinical pharmacy services is dependent on exposure to those services, with use increasing as
resident physicians progress through their training. Resident physicians train within environments that have a multidisciplinary
teaching and clinical care approach, working closely with other healthcare professionals. Ambulatory care pharmacists are increasingly
working with resident physicians in clinic settings as part of the multidisciplinary team, and identification of resident physicians’
perceptions may influence future collaboration.
Objective: The objective of this research is to evaluate the perception of ambulatory care clinical pharmacy services from the
perspective of resident physicians.
Methods: A statewide network of ambulatory care pharmacists was identified and received an electronic questionnaire. Pharmacists
working within clinics that serve as training sites for resident physicians then completed and distributed questionnaires to the resident
physicians within their clinical site. Items related to demographics and perception of involvement and interactions with clinical
pharmacists.
Results: Forty-five resident physicians responded from four unique clinical sites (response rate = 42%). They agreed or strongly agreed
that pharmacists help patients obtain their therapeutic goals (97.8%), are able to educate patients effectively (95.6%), provide high
quality care (97.8%), and do a good job helping co-manage patients (91.1%). Previous exposure to pharmacists was limited primarily to
the drugstore (48.9%) and hospital (51.1%) settings. Resident physicians in the third year of training and those reporting a friend was a
pharmacist, were more likely to have a positive perception of the pharmacist’s role as a resident educator (p=0.048 and p=0.044,
respectively).
Conclusions: Resident physicians with a longer duration of exposure and personal friendship with a pharmacist are more likely to
express positive perceptions. Areas for further enhancements in this interprofessional relationship related to perceptions about
pharmacist autonomy and patient relationships were identified.
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INTRODUCTION
Ambulatory care clinical pharmacy practice has shown
significant recent growth with increased numbers of
pharmacists managing multiple disease states under
collaborative drug therapy management protocols.1 In
addition to preventative care, pharmacists may provide
chronic disease management for a variety of conditions
including the management of diabetes, hypertension, and
dyslipidemia. Under Collaborative Practice Agreements
(CPA) or Collaborative Drug Therapy Management (CDTM)
protocols, prescribers can delegate aspects of patient care
such as initiating, modifying, and discontinuing drug
therapy.2,3 Pharmacists may also order and interpret any
necessary laboratory tests as it pertains to the disease
state(s) being monitored. Physicians' acceptance of clinical
pharmacy services is highly dependent on the level of
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exposure to those services and expectations of pharmacists
are associated with the number of years post-graduation
from medical school, with those physicians who graduated
within the past ten years having higher expectations of
pharmacists.4-6 Expectations include assisting in the design
of drug therapy treatment plans, monitoring response to
drug therapy, and patient education regarding safe and
appropriate use of medications. Additionally, physicians
that are young, group practice-oriented, and write higher
numbers of prescriptions are more likely to utilize, and
have a positive view toward, clinical pharmacy services.6
A collaborative working relationship (CWR) is built in
stages. In order for pharmacists to establish CPAs or CDTM
protocols, the first step is to build strong working
relationships with physicians. The Physician-Pharmacist
Collaborative Instrument (PPCI) measures provider
exchange characteristics through a framework consisting of
five stages: Stage 0 - Professional Awareness, Stage 1 Professional Recognition, Stage 2 - Exploration and Trial,
Stage 3 - Professional Relationship Expansion, Stage 4 Commitment to the Collaborative Working Relationship.7
As the relationship progresses through the various stages,
the establishment of mutual trust and respect is
established, ultimately strengthening the professional
relationship to improve patient outcomes.7 While
progressing to Stage 4 may take time to achieve, pharmacy
residents may be more receptive to this collaboration as
they become familiar with the pharmacist’s professional
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abilities and have confidence in the benefits of the
collaboration.
The Collaboration Among Pharmacists and Physicians To
Improve Outcomes Now (CAPTION) trial evaluated a
physician-pharmacist collaborative model for blood
pressure management and found that pharmacists with
direct patient care improve control of chronic conditions
and should be members of the care team for patients with
hypertension.8 The inclusion of pharmacists on the care
team likely translates to the management of other chronic
conditions, especially those related to cardiovascular
disease.8
Throughout clinical training, resident physicians are placed
within environments that have a multidisciplinary teaching
component requiring working closely with other healthcare
professionals. As part of this multidisciplinary teaching
approach, ambulatory care pharmacists often work with
resident physicians in clinic settings. Approximately 25-50%
of family practice residency programs report the presence
of clinical pharmacists within their program, although
limited data is available describing details of this practice
setting.9,10 First-year resident physicians in family medicine
programs that offer clinical pharmacy services have a more
favorable attitude towards clinical pharmacist’s
participation on the health care team compared to those
residency programs that lack these services. In addition,
these residents prefer to practice as part of a
multidisciplinary team that includes a pharmacist and see
the value in hiring a clinical pharmacist within a private
practice setting.5 Resident physicians value the clinical
pharmacist educator and thought their experiences with
the pharmacist improved their quality of patient care, drug
knowledge, and confidence.11,12
Lastly, the clinical
pharmacist educator was found to positively impact
resident physicians' abilities to work as part of an
interdisciplinary team.12,13
Additional data show that use of clinical pharmacy services
increases as resident physicians progress through their
training programs. This is consistent with the CWR
framework and existing literature on pharmacist-physician
collaboration: development of mutual trust, sustaining the
relationship, and understanding of one another’s role.8,14
Based on reporting of pharmacist-physician encounters,
first- and second-year resident physicians do not fully
utilize clinical pharmacy services, perhaps due to the lack of
education and communication regarding the available
services offered.11,15 Third-year resident physicians may
utilize clinical pharmacy services more frequently due to
increased patient contact, development of a professional
relationship with the clinical pharmacist, and/or a better
understanding of the importance for therapeutic
information.11
Currently, there has not been any literature identified that
has assessed the role of ambulatory care pharmacists from
the viewpoint of resident physicians. Due to the increasing
presence of ambulatory care pharmacists as part of
resident physician clinical training programs and sites, it is
necessary to understand resident physicians' awareness
and perceptions of the capabilities of ambulatory care
pharmacists.9,10 These physicians-in-training can impact
future collaboration, patient care, and expansion of

ambulatory care pharmacy. The purpose of this study is to
evaluate the perception of ambulatory care clinical
pharmacy services from the perspective of resident
physicians in Indiana.
METHODS
In order to identify appropriate participants for this
observational cohort study, a two-step recruitment
strategy was utilized. The first step involved identifying
pharmacists within clinics that serve as a training site for
resident physicians throughout Indiana. The second step
involved seeking pharmacist volunteers to distribute
questionnaires to the resident physicians within their
clinical site. Pharmacists were identified through
convenience sampling based on a comprehensive list
provided by the office of experiential education from
colleges of pharmacy in Indiana, namely Purdue and Butler
Universities. Though there is now a third pharmacy
program within Indiana, at the time this research was
conducted this program had not yet established their
experiential training sites. Inclusion criteria for pharmacist
participation required self-identification as a clinical
practice site that provides longitudinal training for resident
physicians, clinical site located within Indiana, and
willingness to participate. Inclusion criteria for the resident
physicians included currently participating in longitudinal
ambulatory care clinical training at a site that includes an
ambulatory care pharmacist as part of the healthcare team,
clinical practice site located within Indiana, and completing
an Internal Medicine, Family Medicine or Transitional Year
medical residency. All participants were required to be
greater than 18 years old and able to read English.
Pharmacists and resident physicians not meeting the
inclusion criteria were excluded from participation. This
research was deemed exempt by the Indiana University
Institutional Review Board (IRB).
Two unique questionnaires were developed, one to be
completed by ambulatory care clinical pharmacists and one
to be completed by resident physicians. The pharmacist
questionnaire sought to describe the characteristics of their
clinic settings and other aspects of their job. The resident
physician questionnaire sought to assess perceptions and
attitudes regarding working with ambulatory care
pharmacists within clinics. Prior to item creation,
researchers developed five main themes for which to
assess resident physician perceptions and attitudes: quality
of patient care provided by the pharmacist, level of
autonomy provided by the pharmacist, role of the
pharmacist as patient educator, role of the pharmacist as
resident educator, and the pharmacists’ integration within
the clinical care team. These themes were identified based
on researchers’ past experiences with resident physicians
and felt to encompass the unique roles an ambulatory care
clinical pharmacist may be asked to undertake. Five point
Likert scale items ranging from strongly agree to strongly
disagree were developed by researchers for inclusion in the
questionnaires, and had not been previously validated.
Pharmacist Survey
A statewide web-based questionnaire was developed for
ambulatory care clinical pharmacists. An email was sent to
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Table 1. Pharmacist Questionnaire Items and Responses (n=15)
Item
How many pharmacists provide ambulatory care clinical pharmacy services on a regular basis at your individual clinic site? (mean
SD)
What services do you personally provide in your ambulatory care clinic? Please select all that apply.
Disease state education
Drug therapy management
Medication therapy management services
Transitions of care
Wellness visits/disease screening
Formulary approval
Immunizations
Other
What disease states do you provide drug therapy management for based on approved protocol or collaborative practice
agreement? Please select all that apply.
Smoking cessation
Anticoagulation
Hypertension
Diabetes
Hyperlipidemia
Weight loss
COPD
Asthma
Heart failure
Metabolic syndrome
Osteoporosis
Hypothyroidism
GERD
Other(s)
GI (nausea/vomiting/constipation/diarrhea)
HIV
Mental health disorders
Migraine
Pain
Renal impairment/chronic kidney disease
Seizure
What best describes the location of the clinic in which you work with resident physicians?*
Urban
Suburban
Rural
How many half-days per week do you personally provide the clinical pharmacy services identified in question 1, at your practice
site? (mean SD)
How many FTE (full-time equivalent) hours do you personally provide clinical pharmacy services at your clinic site?*
0.1-0.25
0.26-0.50
0.51-0.75
0.76-1
1.1-2
How long have you been providing clinical pharmacy services at your practice site with resident physicians?
< 6 months
6-12 months
1-2 years
2-3 years
3-4 years
4-5 years
5-6 years
> 6 years
*n=14; **n=7

the identified pharmacists asking if their clinic served as a
training site for resident physicians and included a link to
an electronic questionnaire soliciting additional clinical
practice information if they responded affirmatively. Only
data indicating that they were part of an ambulatory care
clinic that served as a training site for resident physicians
were analyzed for the purposes of this study. Descriptive
demographic information focused on the number of clinical
pharmacists within the clinic who worked directly with
resident physicians in a longitudinal manner, the number of

Response n(%)
2.93; SD 1.91

14 (93.3)
14 (93.3)
9 (60)
6 (40)
4 (26.7)
4 (26.7)
1 (6.7)
2 (13.3)

10 (66.7)
8 (53.3)
8 (53.3)
7 (46.7)
7 (46.7)
4 (26.7)
3 (20)
2 (13.3)
2 (13.3)
2 (13.3)
2 (13.3)
1 (6.7)
1 (6.7)
1 (6.7)
-------11 (78.6)
3 (21.4)
-5.07; SD 2.58

1 (7.1)
7 (50)
3 (21.4)
2 (14.3)
1 (7.1)
3 (20)
2 (13.3)
2 (13.3)
2 (13.3)
3 (20)
1 (6.7)
1 (6.7)
1 (6.7)

full-time equivalent hours (FTE) the pharmacist(s) worked
in the clinic, the number of half-days per week dedicated to
providing clinical services, the types of services and
activities that were offered within the longitudinal resident
physician-training clinic and how long they had specifically
provided services in their clinic. Finally, questions were
asked about the types of involvement that the resident
physicians had directly and indirectly with the clinical
pharmacist and how often that interaction occurred.

www.pharmacypractice.org (eISSN: 1886-3655 ISSN: 1885-642X)

3

Meredith AH, Ramsey D, Schmelz A, Berglund R. Resident physicians’ perceptions of ambulatory care pharmacy. Pharmacy
Practice 2019 Jul-Sep;17(3):1509.
https://doi.org/10.18549/PharmPract.2019.3.1509
Table 1 (cont.). Pharmacist Questionnaire Items and Responses (n =15)
Item
How long have clinical pharmacy services been provided by any pharmacist at your clinic site with resident physicians?*
< 6 months
6-12 months
1-2 years
3-4 years
4-5 years
5-6 years
> 6 years
How many resident physicians work at your practice site?
0-5
6-10
11-15
16-20
21-25
26-30
31-35
36-40
> 40
What specialty are the resident physicians at your practice site? (Select all that apply)
Family practice
Internal medicine
Transitional
Other
What is your primary method of communication with the resident physicians at your practice site?*
Face-to-face
Patient chart (paper or electronic)
Electronic communication via EMR
Other
E-mail
Do you provide formal resident physician education at your site?
Yes
No
How often do you provide formal resident physician education at your practice site?**
Quarterly
Monthly
Weekly
More than once per week
2-3 times per month
Annually
In what form do you provide formal resident physician education at your practice site?**
Structured clinical rotation
Formal presentation
Clinical shadowing experience
Preparation of written materials for distribution
Other
How often do resident physicians shadow your clinical encounters?
Never
Weekly
Quarterly
Annually
Monthly
Once throughout residency
*n=14; **n=7

Resident Physician Survey
Pharmacists identified as practicing in a longitudinal
resident physician clinic were asked to forward an
electronic questionnaire link to each resident physician
within their clinic. Due to a low initial resident physician
response rate, this data was discarded and a hard copy
questionnaire was mailed to each participating pharmacist
for the resident physicians within their clinics. All
questionnaires were anonymous and, once complete, were
placed in an envelope that was not located within the
pharmacist’s office or direct workspace to maintain
confidentiality and anonymity. The questionnaire focused
on the perceptions of the resident physician and inquired

Response n(%)
1 (7.1)
-1 (7.1)
2 (14.3)
2 (14.3)
1 (7.1)
7 (50)
2 (13.3)
3 (20)
1 (6.7)
2 (13.3)
-3 (20)
1 (6.7)
-3 (20)
9 (60)
5 (33.3)
2 (13.3)
3 (20)
8 (57.1)
3 (21.4)
2 (14.3)
1 (7.1)
-7 (46.7)
8 (53.3)
3 (42.9)
2 (28.6)
1 (14.3)
1 (14.3)
--2 (28.6)
2 (28.6)
1 (14.3)
-2 (28.6)
6 (40)
3 (20)
2 (13.3%)
2 (13.3%)
1 (6.7)
1 (6.7)

about the types of services the ambulatory care pharmacist
provided within their longitudinal clinic. Additional
demographic information included the type of residency
they were completing, current year of residency, and prior
exposure to pharmacists and/or pharmacy students.
Questionnaires were distributed April 1, 2015 through April
30, 2015. A reminder was electronically sent to
participating pharmacists to encourage the resident
physicians at their clinic to complete the questionnaire.
Data Analysis
Data were analyzed using SPSS 22 (IBM) software. A range
of statistical tests were completed including basic
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Table 2. Resident Physician Demographics
Resident Physician Characteristic
Clinic Location

Response n (%)
Urban
Suburban
Response omitted

36 (80)
8 (17.8)
1 (2.2)

Internal Medicine
Family Practice
Response Omitted

32 (71.1)
12 (26.7)
1 (2.2)

First
Second
Third
Response omitted

17 (37.8)
15 (33.3)
12 (26.7)
1 (2.2)

Face-to-Face
Electronic via EMR
E-mail
Patient Chart
Response omitted

32 (71.1)
10 (22.2)
1 (2.2)
1 (2.2)
1 (2.2)

Type of Medical Residency

Year of Residency

Primary Method of Communication with Pharmacist

Frequency of Patient Referral to Pharmacist Service(s)
Less than once per clinic session, at least once per month
Less than once per month
Never
Response omitted
At least once per clinic session
Frequency of Medication-Related Discussion with Pharmacist
Less than one time each clinic session, at least once per month
Less than once per month
One time each clinic session
Several times each clinic session
Never
Response omitted
Participated in Discussion(s) of the PharmD Curriculum and/or Various Career Options for Pharmacists
No
Yes
Number of Lectures Taught by a Pharmacist During Medical School Education
An entire course
A few lectures
Several lectures
I did not have a pharmacist teach me in medical school
I do not remember, but a pharmacist did teach me
One lecture
Frequency of Collaboration with Pharmacy Students on Projects During Medical School
Not at all
Once during medical school
Each semester
Once per year
Exposure to Pharmacists Before Longitudinal Clinic*
Hospital pharmacy
Team member on inpatient ward as student/intern
Drugstore pharmacy
Ambulatory clinic as student/intern
No prior exposure
Faculty member during medical school was a pharmacist
*Total n=44; resident physicians able to select all applicable responses

descriptive statistics for summarizing demographic
information and frequencies, one-way ANOVA for analyzing
the summed category responses and independent samples
t-test to assess specific demographic items, such as year of
residency and summed category responses, such as role as
resident educator. Prior to project initiation, researchers
determined that means of Likert scale responses would be
reported.16 The significance level (alpha) was predetermined to be 0.05.

22 (48.9)
18 (40)
4 (8.9)
1 (2.2)
-22 (48.9)
12 (26.7)
5 (11.1)
2 (4.4)
2 (4.4)
2 (4.4)
34 (75.6)
11 (24.4)
13 (28.9)
11 (24.4)
10 (22.2)
7 (15.6)
4 (8.9)
-37 (82.2)
8 (17.8)
--23 (51.1)
23 (51.1)
22 (48.9)
6 (13.3)
6 (13.3)
1 (2.2)

RESULTS
A total of 72 pharmacists received an invitation to
participate. These pharmacists represented 51 unique
clinical sites, although it is unknown how many serve as
resident physician longitudinal training sites. Fifteen clinical
pharmacists responded to the questionnaire (response
rate=20.8%). As the clinic location was not a required
response in order to maintain anonymity, it is unclear how
many unique clinic sites these responses represented. Of
the 15 pharmacists that completed the questionnaire, four
agreed to facilitate distribution of the resident physician
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questionnaire. Responding clinical pharmacists within these
medical residency program sites provided a wide range of
services with more than 90% reporting involvement in
disease state education and collaborative drug therapy
management via approved protocol or scope of practice
(Table 1). There was a mean (SD) of approximately three
clinical pharmacists providing services within each site
(2.93; SD 1.91), with each individual pharmacist providing
services over a mean of 5 half-days each week (5.07; SD
2.58). The majority of pharmacists within resident physician
training clinics had been providing services for fewer than
four years. Less than half reported being formally involved
in resident physician education (n=7; 46.7%), with this
education taking the form of shadowing experiences,
structured clinical rotations, and presentations.
It is unknown how many resident physicians received the
initial electronic questionnaire. A total of 107 resident
physicians from four unique clinical sites received printed
questionnaires. Forty-five resident physicians responded
(response rate =42%). Most resident physicians were from
Internal Medicine programs (71%) in urban areas (80%)
with similar representation from all 3 years of their
st
nd
rd
programs (1 : 38%; 2 : 33%; 3 : 27%). Almost half of the
resident physicians referred patients for clinical pharmacy
appointments at least once per month, and the primary
method of communication with the pharmacist was faceto-face (71.1%) rather than through less direct methods
such as email (2.2%) or via the EMR (22.2%) (Table 2).
Resident physicians reported that prior to working with a
pharmacist in their clinical practice sites, most had been
exposed to pharmacists in the drugstore (48.9%) and
hospital (51.1%) settings, with only 13.3% indicating they
had worked with a pharmacist practicing in an ambulatory
clinic as a student or intern. There was a wide spectrum of
exposure to pharmacists in the resident physician medical
school curriculum, with pharmacists’ responsibilities
ranging from no didactic teaching (15.6%) to teaching an
entire course (28.9%). Few resident physicians (24.4%) had
ever discussed the PharmD curriculum and/or various
career field options for pharmacists.
Most resident physicians agreed or strongly agreed that
pharmacists help patients obtain their therapeutic goals
(97.8%), are able to educate patients effectively (95.6%),
provide high quality care (97.8%), and do a good job
helping co-manage patients (91.1%). Despite this, they
reported that clinical pharmacists are given too much
independence in clinical encounters (28.9%) and some
worry that referring patients to a clinical pharmacist hurts
their relationship with their patients (8.8%). Most resident
physicians reported working collaboratively with the clinical
pharmacist at their longitudinal clinic site (82.2%); however
many (26.6%) reported not spending enough time with the
clinical pharmacist to gain an understanding of their
capabilities. Most are confident in the clinical pharmacist’s
abilities to manage patients (97.8%), and more than half
(53.3%) think the pharmacist is qualified to provide
additional services than those currently being offered at
their clinic sites such as management of chronic pain, heart
failure, and weight loss (Table 3).

Resident physicians felt that the clinical pharmacist is a
strong resident educator (73.3%) and most agreed that
they would like the clinical pharmacist to be more formally
involved in their clinical education (84.4%). They believed
pharmacists provide education in a way that is different
from physicians (86.7%) and that they use specific
educational techniques to improve resident physician
understanding of pharmacotherapy (84.4%).
Only four of the demographic items evaluated were
associated with significant differences in responses.
Resident physicians in the third year of their training and
those that reported having a friend that was a pharmacist,
were more likely to have a positive perception of the
pharmacist’s role as a resident educator (p=0.048 and
p=0.044, respectively). Those resident physicians who
referred patients more frequently for clinical pharmacy
appointments or reported prior exposure to pharmacists
practicing in inpatient settings were more likely to respond
favorably to the clinical pharmacist having autonomy with
patient care (p=0.016 and p=0.033, respectively). Also,
resident physicians responding with high levels of
agreement to statements about the integration of
pharmacists within the clinic team were more likely to
report that one of their friends was a pharmacist (p=0.038).
Both pharmacists and resident physicians were asked the
same questions to describe the types of pharmacy services
offered and disease states managed within the clinics
(Table 4). There were differences in pharmacist identified
activities and resident physician identified pharmacist
activities, with resident physicians over-identifying the
types of services the clinical pharmacist provides, as
compared to the pharmacist self-report.
DISCUSSION
Medical resident perceptions of pharmacists have not been
well established in scientific literature. Based on the
findings from this study, resident physicians perceive
pharmacists that work within their longitudinal ambulatory
clinic as providing effective patient education and a high
quality of care to the patients that are referred for clinical
pharmacy services. The majority of respondents indicated
that they strongly agreed or agreed that the pharmacists in
their clinics had the appropriate clinical training to provide
the level of care for the services offered and were
confident in the abilities of the pharmacist with whom they
have a relationship, similar to reports of non-resident
physicians.14,17 Additionally, the majority of resident
physicians in this study either strongly agreed or agreed
that care provided by the pharmacist is different than the
services offered by the physicians. Pharmacists are able to
conduct focused visits for one or two disease states that
incorporate not only pharmacotherapy, but also nonpharmacological elements pertaining to the patient’s
lifestyle such as dietary and physical activity. This varies
from an appointment conducted by a physician that may
need to focus on a wide array of disease states not allowing
for adequate time to fully incorporate pharmacologic and
non-pharmacologic treatment options.
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Table 3. Resident physician questionnaire perception items and responses. n (%)
Item (Category)
The clinical pharmacist at my longitudinal, continuity clinic…
… provides a high quality of care to my patients. (Quality of care)
… helps my patients achieve their goals more quickly than if I managed them alone.
(Quality of care)
… helps patients obtain their therapeutic goals. (Quality of care)
… does a good job helping to co-manage my patients. (Quality of care)
… effectively provides patient education. (Patient educator)
… serves as a reliable source for patient education material. (Patient educator)
… takes into account the individual needs of my patients when providing patient
education. (Patient educator)
… provides education to patients in a way that is different from what a physician
provides. (Patient educator)
… provides care to my patients that is different than the care I provide or the care a
staff physician provides. (Patient educator)
… has the education and training to perform the type of services that they provide.
(Autonomy)
… is qualified to provide additional services that are not currently being offered at my
clinic site. (Autonomy)
… is given too much independence in clinical encounters. (Autonomy)
… is an expert in the therapeutic areas in which he/she provides care. (Autonomy)
… should be given more independence in clinical encounters. (Autonomy)
… is actively involved in my clinical education. (Resident educator)
… is a strong resident educator. (Resident educator)
… uses educational techniques that improve resident understanding of
pharmacotherapy. (Resident educator)
… provides education to residents in a way that is different from what a physician
provides. (Resident educator)
… provides value that is uniquely different from other providers (i.e., physicians, nurses,
dieticians, etc.). (Integration)
… should be involved with making medication-related decisions for patients with
complex medication regimens. (Integration)
… functions as an integrated member of the clinic healthcare team. (Integration)
Ambulatory care clinical pharmacists are able to educate patients effectively to achieve
desired outcomes. (Patient educator)
I spend enough time with the clinical pharmacist to gain an understanding of the
capabilities of ambulatory care pharmacists. (Resident educator)
I would like the clinical pharmacist at my longitudinal clinic to be more formally involved
in my clinical education. (Resident educator)
I work collaboratively with the clinical pharmacist at my longitudinal clinic. (Integration)
I feel comfortable asking the clinical pharmacist at my longitudinal clinic questions
about medication therapy, even if outside of the areas for which he/she currently
provides service. (Integration)
The level of care provided to patients would suffer if there was not a clinical pharmacist
as part of the clinic team. (Integration)
I value the opinion of the clinical pharmacist at my longitudinal clinic on decisions
regarding medication therapy. (Integration)
Ambulatory care pharmacists are able to motivate patients to achieve improved quality
of care. (Quality of care)
Referring patients to a clinical pharmacist for medication management hurts my
relationship with the patient. (Quality of care)
I am confident in the clinical pharmacist’s ability to manage, monitor, and counsel
patients on their medications and disease state(s) based on current guidelines. (Quality
of care)
I am comfortable with the care my patients will receive when referred to the clinical
pharmacist at my longitudinal clinic. (Quality of care)

Perhaps the most surprising finding from this survey is that
despite the resident physicians viewing the pharmacist as
being qualified to provide education and clinical services,
while also being confident in the clinical pharmacists’ ability
to manage, monitor, and counsel patients on their
medications, a small subset of resident physicians felt that
referring patients to the clinical pharmacist for medication
management could hurt their relationships with patients.
While this research was not designed to discover reasons
for these perceptions, a number of possibilities may exist.
These perceptions could be a direct reflection of resident
physicians indicating that they did not get to spend enough
time with the clinical pharmacist to become completely

Strongly
Agree
31 (68.9)

Agree

Neutral

Disagree

13 (28.9)

0 (0)

0 (0)

Strongly
Disagree
1 (2.2)

30 (66.7)

12 (26.7)

3 (6.7)

0 (0)

0 (0)

28 (62.2)
26 (57.8)
29 (64.4)
34 (75.6)

16 (35.6)
15 (33.3)
14 (31.1)
11 (24.4)

1 (2.2)
3 (6.7)
2 (4.4)
0 (0)

0 (0)
1 (2.2)
0 (0)
0 (0)

0 (0)
0 (0)
0 (0)
0 (0)

22 (48.9)

21 (46.7)

2 (4.4)

0 (0)

0 (0)

21 (46.7)

18 (40)

6 (13.3)

0 (0)

0 (0)

20 (44.4)

22 (48.9)

2 (4.4)

1 (2.2)

0 (0)

32 (71.1)

13 (28.9)

0 (0)

0 (0)

0 (0)

13 (28.9)

11 (24.4)

17 (37.8)

3 (6.7)

0 (0)

2 (4.4)
27 (60)
12 (26.7)
17 (37.8)
20 (44.4)

3 (6.7)
16 (35.6)
12 (26.7)
18 (42.2)
13 (28.9)

8 (17.8)
2 (4.4)
16 (35.6)
3 (6.7)
8 (17.8)

23 (51.1)
0 (0)
4 (8.9)
5 (11.1)
3 (6.7)

9 (20)
0 (0)
1 (2.2)
0 (0)
0 (0)

18 (40)

20 (44.4)

6 (13.3)

1 (2.2)

0 (0)

21 (46.7)

18 (40)

4 (8.9)

2 (4.4)

0 (0)

25 (55.6)

17 (37.8)

2 (4.4)

1 (2.2)

0 (0)

21 (46.7)

21 (46.7)

2 (4.4)

1 (2.2)

0 (0)

24 (53.3)

17 (37.8)

4 (8.9)

0 (0)

0 (0)

19 (42.2)

26 (57.8)

0 (0)

0 (0)

0 (0)

6 (13.3)

14 (31.1)

13 (28.9)

11 (24.4)

1 (2.2)

14 (31.1)

24 (53.3)

7 (15.6)

0 (0)

0 (0)

18 (40)

19 (42.2)

7 (15.6)

1 (2.2)

0 (0)

32 (71.1)

13 (28.9)

0 (0)

0 (0)

0 (0)

16 (35.6)

24 (53.3)

2 (4.4)

2 (4.4)

1 (2.2)

26 (57.8)

18 (40)

1 (2.2)

0 (0)

0 (0)

20 (44.4)

20 (44.4)

5 (11.1)

0 (0)

0 (0)

0 (0)

2 (4.4)

2 (4.4)

27 (60)

14 (13.1)

26 (57.8)

18 (40)

1 (2.2)

0 (0)

0 (0)

24 (53.3)

20 (44.4)

1 (2.2)

0 (0)

0 (0)

comfortable with the concept of patient referral and
independent pharmacist management, while also lacking a
full awareness of the disease states managed and broad
scope of services provided by the pharmacist. This could be
remedied through formal shadowing or joint appointments
between the resident physician and clinical pharmacist at
the start of, and periodically throughout, the longitudinal
clinic experience, or simple distribution of a handout during
the resident physician’s first year in clinic that clearly
explains and identifies the various roles of the clinical
pharmacist.
There is a need for increased awareness of the role of the
clinical pharmacist as shown by the discrepancy seen
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Table 4. Comparison of Pharmacist Services. n (%)
Activity/Service
Disease state education
Drug therapy management per protocol or collaborative practice agreement
Formulary approval
Immunizations
Medication Therapy Management Services
Transitions of Care
Wellness visits/Disease screening
Other
Disease States Managed
Anticoagulation
Asthma
COPD
Diabetes
GERD
GI (nausea/vomiting/ constipation/diarrhea)
Heart failure
HIV
Hyperlipidemia
Hypertension
Hypothyroidism
Mental health disorders
Metabolic syndrome
Migraine
Osteoporosis
Pain
Renal impairment/ CKD
Seizure
Smoking cessation
Weight loss
Other(s)

among the responses from pharmacists regarding their
clinical activities compared with the responses from the
resident physicians (Table 4). Of note, only 57.8% of
resident physicians responded that the pharmacist provides
disease state education versus 93.3% of the pharmacists. A
lack of awareness of the pharmacists’ services by resident
physicians may reduce referrals and limit the pharmacist
from being fully utilized in providing patient care at the
practice site. It should be noted that the 15 pharmacists
who responded may practice at up to 15 different sites,
whereas the resident physicians came from only 4 different
practice sites, possibly contributing to the discrepancy
noted between the pharmacists and resident physicians for
services provided. Future research should continue to
explore these hypotheses.
One of the largest benefits to utilizing ambulatory care
pharmacists for patient management is that by allowing the
pharmacist to focus on the management of specific disease
states through frequent follow-up visits, resident physicians
may have more room in their schedules to see medically
complex patients or address additional concerns of patients
for whom chronic disease management would otherwise
dominate their visits. The frequency of patient follow-up
with the pharmacist perhaps plays a part in the perception
that patient referral to the pharmacist hurts the resident
physician’s relationship with the patient, particularly if the
patient is relatively new to the resident physician. Due to
patient panel size, pharmacists are often able to see
patients back every few weeks whereas the first available
resident physician appointment may not be for a few
months.

Resident Response
26 (57.8)
45 (100)
22 (48.9)
5 (11.1)
37 (82.2)
24 (53.3)
19 (42.2)
1 (2.2)
Resident Response
35 (77.8)
23 (51.1)
17 (37.8)
39 (86.7)
5 (11.1)
5 (11.1)
11 (24.4)
7 (15.6)
13 (28.9)
19 (42.2)
10 (22.2)
6 (13.3)
6 (13.3)
6 (13.3)
6 (13.3)
7 (15.6)
8 (17.8)
4 (8.9)
28 (62.2)
13 (28.9)
1 (2.2)

Pharmacist Response
14 (93.3)
14 (93.3)
4 (26.7)
1 (6.7)
9 (60)
6 (40)
4 (26.7)
2 (13.3)
Pharmacist Response
8 (53.3)
2 (13.3)
3 (20)
7 (46.7)
1 (6.7)
0 (0)
2 (13.3)
0 (0)
7 (46.7)
8 (53.3)
1 (6.7)
0 (0)
2 (13.3)
0 (0)
2 (13.3)
0 (0)
0 (0)
0 (0)
10 (66.7)
4 (26.7)
1 (6.7)

Additionally, the concern regarding impact on patient
relationship may support the idea that the resident
physicians would like the pharmacist to be more directly
involved in their clinical education during their ambulatory
care learning experience by leading topic discussions or
providing relevant presentations. In certain settings, such
as what is seen within the Veteran’s Affairs (VA)
environment, the view of the clinical pharmacist’s role in
the approval or denial of non-formulary medication
requests may contribute to this view of “harm” to the
patient relationship. Almost half (48.9%) of the resident
physicians identified non-formulary medication requests as
a service in which their pharmacist was involved. When a
non-formulary medication is denied or an alternate
medication is suggested in place of the non-formulary
medication being requested, this could be viewed by the
resident physician as hindering the relationship the
physician has with the patient.
Slightly more than half of the resident physicians in this
study strongly agreed or agreed that the pharmacist is
qualified to provide additional services than those currently
being offered at their clinics. Resident physicians’ limited
knowledge of the PharmD curriculum and limited
collaboration with pharmacy students on projects during
medical school may be contributing factors as to why a
notable number of resident physicians were neutral and a
few disagreed with pharmacists being able to provide
additional services. Medical and pharmacy schools
throughout the United States are focusing on incorporating
interprofessional education (IPE) into the curriculum. It is
worth noting that residency training, whether pharmacy or
medical, is a perfect venue to implement IPE. While this
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study did not specifically focus on IPE, it is worthwhile to
note that 82.2% of resident physicians had not collaborated
with pharmacy students on any projects during their
medical school training and 13.3% had no prior exposure to
pharmacists prior to starting their longitudinal clinic
experience. While this does not represent all medical
schools, it showcases the struggle that some medical
programs may have with incorporating IPE into professional
school training, and how a lack of IPE early in training can
influence perceptions of working with varied healthcare
disciplines. Additionally, the responses which differed
based on demographic factors all follow what is known
about
establishing
effective
pharmacist-physician
collaboration; colocation, past experiences, and ability to
communicate effectively are important factors in
establishing collaboration.14,18 The responses of resident
physicians that have a friend that is a pharmacist support
these concepts as a deeper relationship has been formed.
Concerted efforts should be made to provide all health care
professionals in training with opportunities to work closely
with trainees from other disciplines, whether through the
completion of multidisciplinary group projects while in
school or some other manner while receiving clinical
training.
One limitation that should be noted is that of survey bias.
While all efforts were made to minimize any bias from the
survey instrument, the use of a hard copy survey
instrument may have impacted resident physicians’
responses if there was concern that responses would be
viewed by the clinical pharmacist with whom they directly
work. Selection bias may also have occurred. Pharmacists
were identified based on established preceptor
relationships with pharmacy programs, which would
exclude any non-preceptor pharmacists from participating.
Additionally, pharmacists were asked to distribute the
questionnaires to all resident physicians at their practice
site, but may have only distributed questionnaires to the
resident physicians at their site with whom they had good
relationships or expected positive feedback from. An
additional limitation is the small sample size and moderate
response rate, however physician response rates to surveys
are typically low and some studies have shown that
response rates in this population are declining over time.1923
Our resident physician response rate of 42% is similar to
other studies.19-22
This research highlights the perceptions of resident
physicians within Indiana and may not be representative of
views throughout the country. Investigators successfully
attempted to increase the response rate following the

initial study pilot period by changing the questionnaire
administration method. However, based on the research
methods it is uncertain how many medical residency
programs include clinical pharmacists as part of the
ambulatory care healthcare team or how many unique
training sites were represented among the 15 pharmacist
responses. Given the small number of distributing
pharmacists, the results may be more of a reflection of
these specific pharmacists rather than overall perceptions
of ambulatory care pharmacy services throughout Indiana,
although aligned with the perceptions of non-resident
physicians.14,17 Researchers attempted to be as
comprehensive as possible in identifying potential sites for
participation, however there is not a master list of
pharmacists practicing in the ambulatory care setting, nor
is there a comprehensive list of longitudinal ambulatory
care training sites for resident physicians in Indiana.
CONCLUSIONS
This novel research highlights the perceptions of
ambulatory care clinical pharmacists within resident
physician longitudinal ambulatory care clinics. Resident
physicians with a longer duration of exposure and personal
friendship with a pharmacist are more likely to express
positive perceptions. Areas for further enhancements in
this interprofessional relationship have been identified
related to perceptions about pharmacist autonomy and
patient relationships.
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